Talking 'Bout (re) Generation
A fun, engaging, sometimes provocative look at the field of stem cell, gene therapy and regenerative medicine research. Who is doing it right, who is doing it wrong, and how you can tell the difference. Why does that matter? Because we are helping change the face of medicine, saving lives and changing lives. There's a lot to talk about. So join us.
Talking 'Bout (re) Generation
Two women in the fight against Lou Gehrig's disease
•
Kevin
Lou Gehrig's disease, or ALS, is a nasty degenerative condition that destroys the brain cells controlling movement. The average life expectancy for someone diagnosed with ALS is just two to five years. It has a devastating impact on the people diagnosed and their families. On the latest episode of Talking 'Bout (re)Generation we talk to two women who have suffered a loss in this fight, but who are using their experience with ALS to help others battling the disease.